Protective effect of Umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 566, Issue 1-3, 2007, Pages 231-239

  Ramesh, Balakrishnan ^a   Viswanathan, Periyasamy ^a   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diabetes mellitus; Fatty acid composition; Streptozotocin; Umbelliferone

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ARACHIDONIC ACID; ASPARTATE AMINOTRANSFERASE; CREATININE; DIMETHYL SULFOXIDE; FATTY ACID; GLIBENCLAMIDE; GLUCOSE; INSULIN; LINOLEIC ACID; LIPID HYDROPEROXIDE; OLEIC ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UMBELLIFERONE; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG SCREENING; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; KIDNEY HEMORRHAGE; KIDNEY MASS; KIDNEY TUBULE CELL; LIPID COMPOSITION; LIVER DISEASE; LIVER LEVEL; LIVER WEIGHT; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; URIC ACID URINE LEVEL; URINE LEVEL;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; INSULIN; KIDNEY; LIPID PEROXIDES; LIVER; MALE; RATS; RATS, WISTAR; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UMBELLIFERONES;

EID: 34249101885     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.03.045     Document Type: Article

References (51)

1. Almdal J.P., and Vilstrup H. Strict insulin therapy normalizes organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia 31 (1988) 114-118
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 (2005) S43-S48
3. Brenner R.R. Regulatory function of Δ6 desaturase-key enzyme of polyunsaturated fatty acid synthesis. Adv. Exp. Med. Biol. 83 (1977) 85-101
4. Burgi W., Briner M., Franken N., and Kessler A.C.H. One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin. Biochem. 21 (1988) 311-314
5. Burtis C.A., and Ashwood E.R. Enzymes. Teitz Fundamentals of Clinical Chemistry. 4th edition (1996), NB Saunders Company, Philadelphia, USA 312-335
6. Caraway W.T. Determination of uric acid in serum by carbonate method. Am. J. Clin. Pathol. 25 (1955) 840-845
7. Castuma J.C., Catala A., and Brenner R.R. Oxidative desaturation of eicosa-8, 11-dienoic acid to eicosa-5, 8, 11-trienoic acid: comparison of different diets on oxidative desaturation at the 5, 6 and 6, 7 positions. J. Lipid Res. 13 (1972) 783-789
8. Connor W.E. α-Linolenic acid in health and disease. Am. J. Clin. Nutr. 69 (1999) 827-828
9. De Lacruz J.P., Villalobos M.A., Carmona J.A., Martin-Romero M., Smith-Agreda J.M., and de la Cuesta F.S. Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. Thromb. Res. 100 (2000) 305-315
10. Eck M.G., Wynn J.O., Carter W.J., and Faas F.H. Fatty acid desaturation in experimental diabetes mellitus. Diabetes 28 (1979) 479-485
11. Faas F.H., and Carter W.J. Altered fatty acid desaturation and microsomal fatty acid composition in the streptozotocin diabetic rat. Lipids 15 (1980) 953-961
12. Fawcett J.K., and Scott J.E. A rapid and precise method for the determination of urea. J. Clin. Pathol. 13 (1960) 156-159
13. Folch J., Lees M., and Sloane Stanly G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
14. Folsom A.R., Ma J., McGovern P.G., and Eckfeldt H. Relation between plasma phospholipid saturation fatty acids and hyperinsulinemia. Metabolism 45 (1996) 223-228
15. Friedmann N., Gellhorn A., and Benjamin W. Synthesis of arachidonic acid from linoleic acid in vivo in diabetic rats. Isr. J. Med. Sci. 2 (1966) 677-682
16. Gallou G., Ruelland A., Legras B., Maugendre D., Allanic H., and Cloarec L. Plasma MDA in type 1 and type 2 diabetes. Clin. Chim. Acta 214 (1993) 227-234
17. In: Gilman A.G., Rall T.W., Nies A.S., and Tayer P. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th eds (1990), Pergman Press, New York 1317-1322
18. Gomes M.B., Lucctetti M.R., Gonacalvez M.F.R., Gazzolla H., Dimetz T., and Matos H. Influence of first morning urine volume, fasting blood and glycosylated Hb on first morning urine albumin excretion. Braz. J. Med. Biol. Res. 30 (1997) 191-196
19. Holman R.T., Johnson S.B., Gerrard J.M., Mauer S.M., Kupcho-Sandberg S., and Brown D.M. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2375-2379
20. Hoult J.R.S., and Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol. 27 (1996) 713-722
21. Jaffe M. Concerning the precipitate produced in normal urine by picric acid and a new reaction of creatinine. Z. Phys. Chem. 10 (1886) 391-400
22. Jamal G.A. Pathogenesis of diabetic neuropathy: the role of the n-6 essentially fatty acids and their eicosanoid derivatives. Diabet. Med. 7 (1990) 574-579
23. Jiang Z.Y., Hunt J.V., and Wolff S.P. Detection of lipid hydroperoxides using the "Fox method". Anal. Biochem. 202 (1992) 384-389
24. Klein R.A. The detection of oxidation in liposome preparation. Biochim. Biophys. Acta 210 (1979) 486-489
25. Marles R.J., and Farnsworth N. Antidiabetic plants and their active constituents: an updates. Prof. J. Bot. Med. 3 (1996) 85-135
26. Mercuri O., Peluffo R.O., and Brenner R.R. Effect of insulin on the oxidative desaturation of α-linolenic, oleic and palmitic acids. Lipids 2 (1967) 284-285
27. Morrison W.R., and Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res 5 (1964) 600-608
28. Nichans W.G., and Samuelson B. Formation of MDA from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 6 (1968) 126-130
29. Noel P.R., Barnett K.C., Davies R.E., Jolly D.W., Leahy J.S., Mawdesley-Thomas L.E., Shillam K.W., Squires P.F., Street A.E., Tucker W.C., and Worden A.N. The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit. Toxicology 3 (1975) 143-169
30. Nourooz-Zedeh J., Rahini A., Tajaddini-Sarmadi J., Tritschler H., Rosen P., Halliwell B., and Betteridge D.J. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40 (1997) 647-653
31. Parmar C., and Kaushal M.K. Aegle marmelos. Wild Fruits (1982), Kalyani Publishers, New Delhi, India 1-5
32. Pearse A.G.E. Histochemistry-Theoretical and Applied. 3rd ed. vol. 1 (1981), Churchill Livingstone
33. Ramesh B., and Pugalendi K.V. Antihyperlipidemic and antidiabetic effects of Umbelliferone in streptozotocin diabetic rats. Yale J. Biol. Med. 78 (2005) 189-196
34. Ramesh B., and Pugalendi K.V. Impact of Umbelliferone on erythrocyte redox status in STZ-diabetic rats. Yale J. Biol. Med. 78 (2005) 133-140
35. Ramesh B., and Pugalendi K.V. Effect of Umbelliferone on cellular redox status in STZ-diabetic rats. W. W. W. J. Biol. 9 (2005) 1
36. Ramesh B., and Pugalendi K.V. Antihyperglycaemic effect of Umbelliferone in STZ-diabetic rats. J. Med. Food. 9 (2006) 562-566
37. Ramesh B., and Pugalendi K.V. Antioxidant role of Umbelliferone in STZ-diabetic rats. Life Sci. 79 (2006) 306-310
38. Ramesh B., and Pugalendi K.V. Influence of Umbelliferone on glycoprotein components in diabetic rats. Toxicol. Mech. Method 17 (2006) 1-7
39. Ramesh B., and Pugalendi K.V. Impact of Umbelliferone (7-hydroxycoumarin) on hepatic marker enzymes in streptozotocin diabetic rats. Ind. J. Pharmacol. 38 (2006) 209-210
40. Reinhold J.G. Manual determination of serum total protein, albumin and globulin fractions by Biuret method. In: Reiner M. (Ed). Standard Methods in Clinical Chemistry (1953), Academic Press, New York 88
41. Roche H.M. Unsaturated fatty acids. Proc. Nutr. Soc. 58 (1999) 397-401
42. Ruiz-Gutierrez V., Stiefel P., Villar J., Garcia-Donas M.A., Acosta D., and Carneado J. Cell membrane fatty acid composition in type 1 (insulin-dependent) diabetic patients: Relationship with sodium transport abnormalities and metabolic control. Diabetologia 36 (1993) 850-856
43. Spector A. Essentiality of fatty acids. Lipids 34 (1999) S1-S3
44. Stubbs C.D., and Smith A.D. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity. Biochim. Biophys. Acta 779 (1984) 89-137
45. Teitz N.W. Fundamentals of Clinical Chemistry (1987), NB Saunders Company, Philadelphia 638
46. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Clin. Biochem. 6 (1969) 24-27
47. Vallabhji J., McColl A.J., Richmond W., Schachter M., Rubens M.B., and Elkeles R.S. Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 24 (2001) 1608-1613
48. Whitehead M.W., Hawkes N.D., Hainsworth I., and Kingham J.G.C. A prospective study of the causes of notably raised aspartate transaminase of liver origin. Gut 45 (1999) 129-133
49. Wohaieb S.A., and Godin D.V. Alteration in free radical tissue defense mechanisms in streptozotocin diabetes in rats: effect of insulin treatment. Diabetes 36 (1987) 1014-1018
50. Wu F.J., and Sheu S.J. Analysis and processing of Chinese herbal drugs: the study of Fructus Aurantii Immaturus (Chin.). Chin. Pharm. J. 44 3 (1992) 257-263
51. Zhang X.F., and Tan B.K. Antihyperglycaemic and antioxidant properties of andrographis particulate in normal and diabetic rats. Clin. Exp. Pharmacol. 27 (2000) 5-6